Cell Death and Disease


, Volume 14, Issue 4, pp 478-500

First online:

Cell death pathways in Parkinson’s disease: proximal triggers, distal effectors, and final steps

  • Oren A. LevyAffiliated withDepartment of Neurology, Columbia University School of Medicine
  • , Cristina MalageladaAffiliated withDepartment of Pathology and Cell Biology, Columbia University School of Medicine
  • , Lloyd A. GreeneAffiliated withDepartment of Pathology and Cell Biology, Columbia University School of Medicine Email author 

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


Parkinson’s disease (PD) is a common neurodegenerative disorder. Neuronal cell death in PD is still poorly understood, despite a wealth of potential pathogenic mechanisms and pathways. Defects in several cellular systems have been implicated as early triggers that start cells down the road toward neuronal death. These include abnormal protein accumulation, particularly of alpha-synuclein; altered protein degradation via multiple pathways; mitochondrial dysfunction; oxidative stress; neuroinflammation; and dysregulated kinase signaling. As dysfunction in these systems mounts, pathways that are more explicitly involved in cell death become recruited. These include JNK signaling, p53 activation, cell cycle re-activation, and signaling through bcl-2 family proteins. Eventually, neurons become overwhelmed and degenerate; however, even the mechanism of final cell death in PD is still unsettled. In this review, we will discuss cell death triggers and effectors that are relevant to PD, highlighting important unresolved issues and implications for the development of neuroprotective therapies.


Parkinson’s disease Apoptosis Neuroprotection Alpha-synuclein